Is This the Top for Astex Pharmaceuticals, Inc. (ASTX)

Zacks

Astex Pharmaceuticals, Inc. (ASTX) has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because ASTX is now in overbought territory with an RSI value of 71.5. Furthermore, estimates for the Astex Pharmaceuticals, Inc. have been coming down, pushing it to a Zacks Rank #4 (Sell). This suggests that investors may better off exiting this stock before it falls back to Earth.
ASTEX PHARMACEUTICALS INC (ASTX): Free Stock Analysis ReportZacks Investment Research

Rates

View Comments (0)